A Single-Center, Prospective, Investigator Initiated, Observational Study To Evaluate The Visual Outcomes And Patient Satisfaction After Acrysofvivity Iol Implantation In Patients With Mild Irregular Astigmatism
Published 2025 - 43rd Congress of the ESCRS
Reference: PO445 | Type: Free paper | DOI: 10.82333/64ak-ka35
Authors: Kjell Gunnar Gundersen 1 , Steffen Østenstad* 1 , Viswanathan Ramasubramanian 2
1Eye,iFocus Øyeklinikk,Haugesund,Norway, 2R&D,Alcon Research LLC,Forth Worth,United States
Purpose
To evaluate the visual outcomes following implantation of Vivity IOL in patients with mild irregular astigmatism
Setting
This prospective, single center, single arm, observational study will include 21 eyes from 21 subjects aged ≥ 45 years. Patients with age related cataract and mild irregular corneal astigmatism defined as mean keratometry values ≤ 47 D, Keratoconus Index showing superior- inferior asymmetry ≤ 1.4 D, Surface Regularity Index between 0.56 and 1.55, CCT 500 to 560 µm with implantation of AcrySofVivity IOL had participated in the study.
Methods
Enrolled subjects in the study, manifest refraction and monocular Visual Acuity (VA) at 6m, 66cm and 40 cm is being recorded at month 1and 3 post-op visit. Subjects also completed Patient Reported Spectacle Independence Questionnaire (PRISQ) for patient satisfaction and Vision related functioning questionnaire using Visual Function Index –VF-14 QOL at month 3 visit.
Results
EXPECTED OUTCOME
The primary outcome will be monocular best corrected distance VA. Secondary outcomes include monocular uncorrected VA (distance, intermediate, near), monocular distance corrected intermediate VA, distance corrected near VA, exploratory endpoints PRISQ and VF-14 QOL. Descriptive and inferential statistics will be used to analyse the outcomes.
Conclusions
We have achieved AcrySofVivity IOL implantation has resulted in the improvement of VA and increased level of spectacle independence and patient satisfaction of visual functions